Role of angiogenesis in the progression and treatment of prostate cancer

Cancer Invest. 2001;19(2):181-91. doi: 10.1081/cnv-100000152.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Androgens / physiology
  • Angiogenesis Inhibitors / therapeutic use*
  • Cytokines / physiology
  • Disease Progression
  • Endothelial Growth Factors / physiology
  • Humans
  • Lymphokines / physiology
  • Male
  • Neovascularization, Pathologic*
  • Prostatic Neoplasms / blood supply
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / physiopathology*
  • Prostatic Neoplasms / therapy*
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Androgens
  • Angiogenesis Inhibitors
  • Cytokines
  • Endothelial Growth Factors
  • Lymphokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors